𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies

✍ Scribed by López-Pedrera, C; Barbarroja, N; Dorado, G; Siendones, E; Velasco, F

Book ID
110056782
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
278 KB
Volume
20
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiogenic potential of malignant and no
Angiogenic potential of malignant and non-malignant human breast tissues in an in vivo angiogenesis model
✍ Hera C. Lichtenbeld; Annemarie F. Barendsz-Janson; Helma van Essen; Harry Struij 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 567 KB

Tumors need to acquire an angiogenic phenotype for outgrowth and metastasis formation. Limited information on the angiogenic potential of specific tissues, especially human breast tissues is available. Here we describe an in vivo model, using the dorsal skin fold chamber in immunodeficient nude mice

Clinical implications of the tumor necro
Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders : A short review
✍ Anas Younes; Bharat B. Aggarwall 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

## Abstract Tumor necrosis factor (TNF), originally identified as a factor produced in the serum of endotoxin‐injected animals, is a cytokine that mediates tumor necrosis. To date, 20 different members of the TNF superfamily and 21 different receptors have been identified. All ligands of the TNF su

Immunodetection and quantification of va
Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues
✍ Hiroko Bando; Maren Brokelmann; Masakazu Toi; Kari Alitalo; Jonathan P. Sleeman; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 303 KB

## Abstract Vascular endothelial growth factor recpetor‐3 (VEGFR‐3) and its ligands, vascular endothelial growth factor‐C (VEGF‐C) and –D (VEGF‐D), are the major molecules involved in developmental and pathological lymphangiogenesis. Here we describe for the first time the development of a specific